BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Strides Pharma Science Ltd. Share Price

NSE
BSE

NSE : STAR

BSE : 532531

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

₹1,131.10

High

₹1,160.30

Price Summary

Previous Close ₹1,136.80
Day's Range ₹1,131.10 - ₹1,160.30
Open ₹1,160.30
52 Week Range ₹680.00 - ₹1,231.00
Volume 79,551
Market Cap ₹0.01
Previous Close ₹1,140.65
Day's Range ₹1,130.70 - ₹1,160.00
Open ₹1,143.70
52 Week Range ₹681.05 - ₹1,231.45
Volume 2,829
Market Cap ₹0.01

Stocks Summary

Trade Value ( ₹ in Lacs) 904.34
Market Cap (₹ in Mn) 0.01
Dividend Yield(%) 0.44
Price/Earning (TTM) 18.93
TTM EPS (₹) 60.34
P/E Ratio 1.72
Book Value(₹) 3.39
PAT Margin (%) 5.77
Face Value (₹) 10.00
ROCE(%) 16.56
Trade Value ( ₹ in Lacs) 32.27
Market Cap (₹ in Mn) 0.01
Dividend Yield(%) 0.44
Price/Earning (TTM) 18.93
TTM EPS (₹) 60.34
P/E Ratio 1.72
Book Value(₹) 3.39
PAT Margin (%) 5.77
Face Value (₹) 10.00
ROCE(%) 16.56

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 11903.93 45653.35
Expenses N/A N/A
PBT 1063.77 4869.21
Operating profit 0.0 0.0
Net profit 856.18 35975.12

Shareholding Pattern

Promoters (% Holding)

27.91%

Mutual funds (% Holding)

8.56%

Non-Institution (% Holding)

28.95%

FI/Banks/Insurance (% Holding)

4.55%

Government (% Holding)

0.01%

FII

28.68%

About Strides Pharma Science Ltd.

Founded 1990
Managing Director Badree Komandur
NSE Symbol STAR

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,51,194.94 1,874.00 1,548.00 - 1,548.00
Divi's Laboratories Ltd. 1,82,992.80 6,855.50 5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd. 1,49,926.25 4,458.30 3,102.00 - 3,102.00
Apollo Hospitals Enterprise Ltd. 1,16,446.16 8,320.00 6,696.50 - 6,696.50
Cipla Ltd. 1,13,051.69 1,403.40 1,165.70 - 1,165.70
Dr. Reddy's Laboratories Ltd. 1,10,333.30 1,321.15 1,148.40 - 1,148.40
Mankind Pharma Ltd. 1,06,668.90 2,511.10 1,909.70 - 1,909.70
Max Healthcare Institute Ltd. 1,04,750.23 1,096.55 903.00 - 903.00
Zydus Lifesciences Ltd. 1,04,743.93 1,030.80 835.50 - 835.50
Lupin Ltd. 1,04,400.67 2,278.00 1,836.80 - 1,836.80
no-content No Records Found

Latest News

May
20
2026
EQUITY Posted on May 20th 2026

Strides Pharma Science informs about informs about disclosure

With reference to intimation of May 15, 2025, regarding the proposed Scheme of Arrangement for Demerger involving Arco Lab, wholly owned subsidiary of Strides and Pivot Path, wholly owned subsidiary of Arco Lab. The Scheme provides for the demerger of Arco Lab’s Life Sciences business and Digital Innovation business (the Demerged Undertaking) into Pivot Path, pursuant to Sections 230–232 of the Companies Act, 2013 and other applicable provisions of the Act and the Rules framed thereunder (Scheme); Strides Pharma Science has informed that the aforesaid Scheme was listed for pronouncement of order before the Hon’ble National Company Law Tribunal, Bengaluru Bench (NCLT) on May 18, 2026, and the NCLT has approved the said Scheme. The final order approving the demerger was made available on the NCLT portal on May 20, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
May
18
2026
EQUITY Posted on May 18th 2026

Strides Pharma Science informs about update to earnings call

With reference to its intimation dated May 11, 2026, regarding the Earnings Call invite for investors and analysts to discuss the audited financial results of the Company for the quarter and financial year ended March 31, 2026, which is scheduled today, May 18, 2026. Strides Pharma Science has informed that US time for the said Earnings Call is 7:30 am EDT (instead of 6:30 am EST as communicated earlier). Updated timing for Earnings Call scheduled today is ‘5:00 PM IST/ 11:30 AM GMT/ 7:30 AM EDT/ 7:30 PM HKT’.

The above information is a part of company’s filings submitted to BSE.

Read More
May
21
2026
EQUITY Posted on May 21st 2026

Bliss GVS Pharma informs about disclosure

Bliss GVS Pharma has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Punita Sharma & PACs.
The above information is a part of company’s filings submitted to BSE.
Read More
May
21
2026
COMPANY Posted on May 21st 2026

Looks Health Service - Quaterly Results

The sales is pegged at Rs. 1.24 millions for the March 2026 quarter. The mentioned figure indicates a decline of about -68.61% as against Rs. 3.95 millions during the year-ago period.Net Profit for the quarter ended March 2026 dipped to Rs. 0.08  millions from Rs. 1.88 millions  in the corresponding previous quarter.A decline of 0.46 millions was observed in the OP in the quarter ended March 2026 from 2.44 millions on QoQ basis.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 1.24 3.95 -68.61 3.88 3.95 -1.77 3.88 3.95 -1.77
Other Income 0.01 0.43 -97.67 0.04 3.90 -98.97 0.04 3.90 -98.97
PBIDT 0.46 2.44 -81.15 1.74 1.70 2.35 1.74 1.70 2.35
Interest 0.00 0.00 0.00 0.01 0.00 0.00 0.01 0.00 0.00
PBDT 0.46 2.44 -81.15 1.73 1.70 1.76 1.73 1.70 1.76
Depreciation 0.35 0.35 0.00 1.42 1.42 0.00 1.42 1.42 0.00
PBT 0.11 2.09 -94.74 0.31 0.28 10.71 0.31 0.28 10.71
TAX 0.03 0.21 -85.71 0.08 0.05 60.00 0.08 0.05 60.00
Deferred Tax -0.06 -0.06 0.00 -0.24 -0.22 9.09 -0.24 -0.22 9.09
PAT 0.08 1.88 -95.74 0.23 0.23 0.00 0.23 0.23 0.00
Equity 105.00 105.00 0.00 105.00 105.00 0.00 105.00 105.00 0.00
PBIDTM(%) 37.10 61.77 -39.95 44.85 43.04 4.20 44.85 43.04 4.20
Read More
May
21
2026
COMPANY Posted on May 21st 2026

Apollo Hospital Ent. - Quaterly Results

A fair growth of 17.50% in the revenue at Rs. 24385.00 millions was reported in the March 2026 quarter as compared to Rs. 20753.00 millions during year-ago period.A slim rise of 14.70% was recorded in the Net profit for the quarter ended March 2026 to Rs. 3824.00  millions  From Rs. 3334.00 millions.Operating Profit saw a handsome growth to 6858.00 millions from 6129.00 millions in the quarter ended March 2026.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 24385.00 20753.00 17.50 93262.00 82021.00 13.71 93262.00 82021.00 13.71
Other Income 903.00 916.00 -1.42 3718.00 3477.00 6.93 3718.00 3477.00 6.93
PBIDT 6858.00 6129.00 11.89 26998.00 23919.00 12.87 26998.00 23919.00 12.87
Interest 634.00 631.00 0.48 2417.00 2540.00 -4.84 2417.00 2540.00 -4.84
PBDT 6224.00 5498.00 13.20 24467.00 21379.00 14.44 24467.00 21379.00 14.44
Depreciation 1280.00 1298.00 -1.39 5004.00 4494.00 11.35 5004.00 4494.00 11.35
PBT 4944.00 4200.00 17.71 19463.00 16885.00 15.27 19463.00 16885.00 15.27
TAX 1120.00 866.00 29.33 4537.00 3922.00 15.68 4537.00 3922.00 15.68
Deferred Tax -262.00 -126.00 107.94 -36.00 -133.00 -72.93 -36.00 -133.00 -72.93
PAT 3824.00 3334.00 14.70 14926.00 12963.00 15.14 14926.00 12963.00 15.14
Equity 719.00 719.00 0.00 719.00 719.00 0.00 719.00 719.00 0.00
PBIDTM(%) 28.12 29.53 -4.77 28.95 29.16 -0.73 28.95 29.16 -0.73
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Strides Pharma Science Ltd. ?

The current share price of Strides Pharma Science Ltd. is ₹1,136.80 as of 2026-05-21.

The market capitalisation of Strides Pharma Science Ltd. is ₹10,526.58 as of 2026-05-20.

The 1-year return of Strides Pharma Science Ltd. is -4.90% as of 2026-05-21.

The P/E ratio of Strides Pharma Science Ltd. is 1.72 as of 2026-05-21.

The 52-week high and low of Strides Pharma Science Ltd. are ₹1,231.00 and ₹680.00, respectively, as of 2026-05-21.

The dividend yield of Strides Pharma Science Ltd. is 0.4378% as of2026-05-20.

You can buy Strides Pharma Science Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Strides Pharma Science Ltd. is Badree Komandur.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore